Delivery Order SPE2DB20D3304-SPE2DB26FW4L0
Award Date 10/31/25
Potential Completion Date 11/3/25
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,038.55 to AmerisourceBergen Drug Corp for MONOVISC 88 mg/4 ml syringes (4 ml quantity) on October 27, 2025, with an ultimate completion date of October 28, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,409.96 to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 ml syringes on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed price, non-set-aside contract represents a single delivery order fulfillment under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $12,223.51 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 mL syringes on September 26, 2025, with completion targeted for September 29, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating competitive award to this pharmaceutical distributor. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $8,318.78 delivery order to AmerisourceBergen Drug Corp for MONOVISC 88 mg/4 mL syringes (4 mL quantity) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-set-aside, competitively awarded contract features firm fixed pricing and represents a routine pharmaceutical supply delivery. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,353.59 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Monovisc 88 mg/4 ml syringes. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of August 28, 2025. The product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,096.73 to AmerisourceBergen Drug Corp for the supply of MONOVISC 88 MG/4 ML syringes (4 ML quantity) on August 12, 2025, with a completion date of August 13, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,453.60 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 mL syringes on August 18, 2025, with an ultimate completion date of August 19, 2025. This delivery order, issued on a firm fixed-price basis with no set-aside designation, represents a competitive award for pharmaceutical supplies to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Monovisc 88 mg/4 mL syringes with a ceiling value of $4.17K. This is a firm fixed-price, competitively awarded contract with no set-aside designation, and is scheduled for completion by May 28, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $16,244.34 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 mL syringes. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. The delivery order is scheduled for completion by September 16, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Monovisc 88 mg/4 mL syringes with a ceiling value of $5,672.46. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 15, 2025. This delivery order is issued under...